Peripheral surrogates of tumor burden to guide therapeutic strategies for HPV-associated malignancies
2023-08-14
(Press-News.org)
“We discuss existing clinical data on these surrogates of tumor burden and their potential in evaluating efficacy of immunotherapy in HPV-associated malignancies.”
BUFFALO, NY- August 14, 2023 – A new review paper was published in Oncotarget's Volume 14 on August 10, 2023, entitled, “Peripheral surrogates of tumor burden to guide chemotherapeutic and immunotherapeutic strategies for HPV-associated malignancies.”
With the rapid adoption of immunotherapy into clinical practice for HPV-associated malignancies, assessing tumor burden using “liquid biopsies” would further our understanding of clinical outcomes mediated by immunotherapy and allow for tailoring of treatment based on real-time tumor dynamics.
In their new review, researchers Meghali Goswami, Jeffrey Schlom and Renee N. Donahue from the National Cancer Institute examine translational studies on peripheral surrogates of tumor burden derived from peripheral blood in HPV-associated malignancies, including levels and methylation of circulating tumor DNA (ctDNA), miRNA derived from extracellular vesicles, circulating tumor cells (CTCs), and HPV-specific antibodies and T cell responses.
“We review their utility as prognostic and predictive biomarkers of response to chemotherapy and radiation, with a focus on how they may inform and guide immunotherapies to treat locally advanced and metastatic HPV-associated malignancies. We also highlight unanswered questions that must be addressed to translate and integrate these peripheral tumor biomarkers into the clinic.”
Read the full review: DOI: https://doi.org/10.18632/oncotarget.28487
Correspondence to: Jeffrey Schlom
Email: schlomj@mail.nih.gov
Keywords: HPV-associated malignancies, immunotherapy, circulating tumor DNA, circulating tumor cells, HPV-specific antibodies
About Oncotarget: Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
To learn more about Oncotarget, visit Oncotarget.com and connect with us on social media:
Twitter
Facebook
YouTube
Instagram
LinkedIn
Pinterest
LabTube
Soundcloud
Sign up for free Altmetric alerts about this article: https://oncotarget.altmetric.com/details/email_updates?id=10.18632%2Foncotarget.28487
Click here to subscribe to Oncotarget publication updates.
For media inquiries, please contact: media@impactjournals.com.
Oncotarget Journal Office
6666 East Quaker Str., Suite 1A
Orchard Park, NY 14127
Phone: 1-800-922-0957 (option 2)
###
END
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
2023-08-14
When it comes to translational medicine, Robert Gourdie is among the 2 percent of “super-producers,” National Institutes of Health-funded scientists at U.S. biomedical institutions who hold 10 or more issued patents.
Super-producers were responsible for half of all patents issued according to research published Aug. 11 in Nature Biotechnology. The objective of the research was to create a tool to better quantify bridges and barriers to clinical translation of biomedical discoveries.
The research marks a novel area of inquiry for Gourdie, a professor and cell biologist at the Fralin Biomedical ...
2023-08-14
In the rush to harness artificial intelligence and machine learning tools to make care more efficient at hospitals nationwide, a new study points to another possible use: identifying patients with non-medical needs that could affect their health and ability to receive care.
These social determinants of health – everything from transportation and housing to food supply and availability of family and friends as supports – can play a major role in a patient’s health and use of health care services.
The new study ...
2023-08-14
A new study from clinicians and researchers at the University of Michigan Rogel Cancer Center, U-M Department of Pathology and the Michigan Center for Translational Pathology reveals findings from over 800 clinical assays performed for kidney patients with MiTF family gene mutations. This study, published in the American Journal of Clinical Pathology¸ is the largest series of its kind in kidney cancer and carries deep clinical and diagnostics implications.
The team, led by Rohit Mehra, M.D., performed over 800 clinical assays on the MiTF family genes TFE3 and TFEB in renal tumors with morphologic and biomarker alterations considered suspicious for MiTF family genetic mutations.
The ...
2023-08-14
The latest study about of proboscideans (elephants and their ancient relatives) from the University of Helsinki provides proof that some proboscideans started to adapt to locally grass-rich environments in East Africa first by changing their behavior and starting to feed more on grasses. This happened in some lineages of proboscideans, such as choerolophodonts, much earlier than has been thought until now, about 23 to 11 million years ago in parts of East Africa
Also, around 7 million years ago in the lake Turkana region, increasingly grass-rich diets of the earliest true ...
2023-08-14
CLEVELAND: A first-in-human trial of deep brain stimulation (DBS) for post-stroke rehabilitation patients by Cleveland Clinic researchers has shown that using DBS to target the dentate nucleus – which regulates fine-control of voluntary movements, cognition, language, and sensory functions in the brain – is safe and feasible.
The EDEN trial (Electrical Stimulation of the Dentate Nucleus for Upper Extremity Hemiparesis Due to Ischemic Stroke) also shows that the majority of participants (nine out of 12) demonstrated ...
2023-08-14
What drives us to develop new ideas rather than settling for standard methods and processes? What triggers the desire to innovate at the risk of sacrificing time, energy, and reputation for a resounding failure? Creativity is based on complex mechanisms that we are only beginning to understand and in which motivation plays a central role. But pursuing a goal is not enough to explain why we favor some ideas over others and whether that choice benefits the success of our actions.
"Creativity can be defined as the ability to produce original ...
2023-08-14
Megumi Inoue, Associate Professor, Social Work, received funding for: "Group Digital Gaming: Experiences of Older Adults Living with Dementia in an Activity for Cognitive Impairment."
The purpose of this study is to examine the effects of a group digital gaming intervention on cognitive function, mood, and behaviors in people with early to moderate levels of dementia. A group digital gaming company, called Obie Technology, was developed to facilitate cognitive stimulation, physical exercise, and group interactions simultaneously. ...
2023-08-14
James C. Witte, Professor, Sociology, Director, Institute for Immigration Research (IIR), and Michelle S. Dromgold-Sermen, Assistant Director, IIR, received funding for: "Refugee Resettlement and STEM Education."
This conference will focus on how STEM-oriented educational opportunities through high schools, registered apprenticeships, community college, and four-year institutions can all play a significant role in addressing urgent humanitarian needs, while also expanding the nation’s STEM workforce.
Participants will learn about the current refugee situation, how the Welcome Corps is a valuable addition to U.S. refugee ...
2023-08-14
Most people in Canada now have hybrid immunity against SARS-CoV-2 through a mix of infection and vaccination, new research in CMAJ (Canadian Medical Association Journal) shows.
VIEW EMBARGOED ARTICLE
Using pan-Canadian blood sample data from a subset of studies backed by the COVID-19 Immunity Task Force (CITF), researchers from the CITF, in collaboration with those from supported studies, estimated changing levels of seroprevalence — from infection or vaccination, or both — over 3 time periods: prevaccination (March to November 2020), vaccine roll-out (December 2020 to November 2021) and the Omicron waves (December 2021 to March 2023). In the first 2 phases, seroprevalence from ...
2023-08-14
NEW YORK, NY (Aug. 14, 2023)--Columbia researchers have identified brain injuries that may underlie hidden consciousness, a puzzling phenomenon in which brain-injured patients are unable to respond to simple commands, making them appear unconscious despite having some level of awareness.
“Our study suggests that patients with hidden consciousness can hear and comprehend verbal commands, but they cannot carry out those commands because of injuries in brain circuits that relay instructions from the brain to the muscles,” says study leader Jan Claassen, MD, associate professor of neurology at Columbia University Vagelos College of Physicians ...
LAST 30 PRESS RELEASES:
[Press-News.org] Peripheral surrogates of tumor burden to guide therapeutic strategies for HPV-associated malignancies
